Higher meat consumption tied to higher psoriasis severity, while higher plant-based consumption tied to lower severity

Keratin, comedo-like openings, and fissures and ridges better seen under UV-FD, as was border definition of lesions

Biologics provide largest quality-of-life gain; for patients, mean willingness to pay was highest for biologics

GLP-1 RAs linked to increased risk for androgenetic alopecia, nonscarring hair loss, telogen effluvium at six months

Patients who responded to their first Janus kinase inhibitor were more likely to respond to a second one

Overall, 64.2 and 61.1 percent of patients correctly defined clear margins and pathology results, while only 13.6 percent understood actinic

Patients prefer simplicity, while clinicians prefer an emphasis on details; staged approach balances these preferences

Overall survival differences were not statistically significant, but survival data were limited

Incidence of hyperkalemia is 10.1 percent and increased in older patients, those with one or more predisposing comorbidities

About half of patients with esophageal cancer presented with stage IV disease; 70.5 percent did not undergo surgical resection

71 percent of patients had pathological complete response; 7 percent experienced grade 3 treatment-related adverse events

All lesions in children and adults resolved after an average of 2.1 treatments

Agent Orange exposure linked to higher odds of AM compared with patients with cutaneous melanoma and controls with no melanoma

Ensemble integrating three architectures achieved area under the curve of 0.9208, outperforming individual models

Patients often experience climate-related triggers, but few reported that their dermatologist addressed these concerns

28.06 percent of the association between DII/DOBS and skin cancer was mediated by PhenoAge

Due to overlap with other pediatric conditions and low clinical suspicion, diagnostic delays are common

Psoriatic arthritis is often missed until irreversible joint damage has occurred, but dermatology clinicians can change that. This article highlights how routine use of...

Median lead time 2.7 months between first positive ctDNA and clinical recurrence

Transmasculine individuals have the highest acne risk in the first year after initiation of testosterone

Significant associations seen for autoimmune, endocrine, neurological, and mental health comorbidities

Significantly reduced risk for disease progression or death seen with toripalimab versus dacarbazine, including in acral melanoma

Higher percentage reductions in Eczema Area and Severity Index seen with 80 mg ICP-332, 120 mg ICP-332 versus placebo